<p>Patient characteristics at start of therapy (baseline, BL) with n = 8 for ECP 80 mmHg and n = 7 for 300 mmHg group, respectively.</p
<p>The patients’ baseline characteristics before antiviral therapy (n = 196).</p
<p>Baseline characteristics of patients according to baseline serum ALP tertile.</p
<p>Baseline Characteristics of Patients According to Quartiles of Baseline NLR Level.</p
Baseline characteristics of the patients in the per-protocol population (n = 54).</p
<p>Baseline clinical and demographic characteristics of enrolled patients (n = 26).</p
<p>Baseline characteristics of patients at the time of initiation of Tuberculosis (TB) therapy (N = ...
Baseline characteristics of all included patients (n = 10) and those used for analysis (n = 8).</p
Main sample patient characteristics at baseline (n = 54) compared to patients included in the sensit...
<p>Baseline characteristics for the patients in the <5 drugs and ≥5 drugs subgroups.</p
<p>Characteristics of hypertensive patients at baseline (T0) and after 6-months antihypertensive the...
<p>Patient characteristics and laboratory data at baseline in all patients and patients grouped acco...
<p>Baseline characteristics of all patients who started treatment with PegIFN/RBV.</p
<p>Baseline patient characteristics by guideline exposure and eligibility group, <i>n</i> = 34,857.<...
<p>Clinical Characteristics of the patients who participated in study (n = 60).</p
<p>Baseline characteristics of the patients with EMB selected for GEP analysis.</p
<p>The patients’ baseline characteristics before antiviral therapy (n = 196).</p
<p>Baseline characteristics of patients according to baseline serum ALP tertile.</p
<p>Baseline Characteristics of Patients According to Quartiles of Baseline NLR Level.</p
Baseline characteristics of the patients in the per-protocol population (n = 54).</p
<p>Baseline clinical and demographic characteristics of enrolled patients (n = 26).</p
<p>Baseline characteristics of patients at the time of initiation of Tuberculosis (TB) therapy (N = ...
Baseline characteristics of all included patients (n = 10) and those used for analysis (n = 8).</p
Main sample patient characteristics at baseline (n = 54) compared to patients included in the sensit...
<p>Baseline characteristics for the patients in the <5 drugs and ≥5 drugs subgroups.</p
<p>Characteristics of hypertensive patients at baseline (T0) and after 6-months antihypertensive the...
<p>Patient characteristics and laboratory data at baseline in all patients and patients grouped acco...
<p>Baseline characteristics of all patients who started treatment with PegIFN/RBV.</p
<p>Baseline patient characteristics by guideline exposure and eligibility group, <i>n</i> = 34,857.<...
<p>Clinical Characteristics of the patients who participated in study (n = 60).</p
<p>Baseline characteristics of the patients with EMB selected for GEP analysis.</p
<p>The patients’ baseline characteristics before antiviral therapy (n = 196).</p
<p>Baseline characteristics of patients according to baseline serum ALP tertile.</p
<p>Baseline Characteristics of Patients According to Quartiles of Baseline NLR Level.</p
DOI
Add to ORKG